JPMorgan Chase & Co. Sells 3,555 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

JPMorgan Chase & Co. cut its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 19.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,562 shares of the company’s stock after selling 3,555 shares during the period. JPMorgan Chase & Co. owned 0.12% of U.S. Physical Therapy worth $880,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Invictus RG acquired a new position in U.S. Physical Therapy during the first quarter worth $100,000. Sei Investments Co. raised its position in U.S. Physical Therapy by 9.0% during the first quarter. Sei Investments Co. now owns 1,954 shares of the company’s stock worth $128,000 after acquiring an additional 162 shares during the period. State of Alaska Department of Revenue raised its position in U.S. Physical Therapy by 77.8% during the second quarter. State of Alaska Department of Revenue now owns 2,454 shares of the company’s stock worth $148,000 after acquiring an additional 1,074 shares during the period. Mason Street Advisors LLC raised its position in U.S. Physical Therapy by 7.0% during the first quarter. Mason Street Advisors LLC now owns 2,928 shares of the company’s stock worth $191,000 after acquiring an additional 192 shares during the period. Finally, Municipal Employees Retirement System of Michigan raised its position in U.S. Physical Therapy by 3.1% during the second quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock worth $178,000 after acquiring an additional 90 shares during the period. 94.55% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities research analysts have recently commented on USPH shares. BidaskClub cut shares of U.S. Physical Therapy from a “sell” rating to a “strong sell” rating in a research report on Sunday, July 16th. Cantor Fitzgerald started coverage on shares of U.S. Physical Therapy in a report on Monday, July 24th. They issued an “overweight” rating and a $72.00 price objective for the company. Jefferies Group LLC set a $65.00 price objective on shares of U.S. Physical Therapy and gave the company a “hold” rating in a report on Friday, August 4th. Zacks Investment Research lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Saturday, August 19th. Finally, Sidoti raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price objective for the company from $62.00 to $74.00 in a report on Friday, September 8th. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $69.00.

In other U.S. Physical Therapy news, COO Glenn Mcdowell sold 1,004 shares of the business’s stock in a transaction dated Tuesday, August 29th. The stock was sold at an average price of $57.01, for a total value of $57,238.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Lawrance W. Mcafee sold 3,000 shares of the business’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $62.04, for a total value of $186,120.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 13,266 shares of company stock valued at $801,134. 3.10% of the stock is owned by insiders.

U.S. Physical Therapy, Inc. (NYSE USPH) traded down $0.45 during midday trading on Monday, hitting $65.85. 25,099 shares of the stock traded hands, compared to its average volume of 67,940. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.04 and a quick ratio of 2.26. The firm has a market cap of $834.14, a PE ratio of 32.03, a price-to-earnings-growth ratio of 2.83 and a beta of 1.07.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $0.48 EPS for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.04). U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. The company had revenue of $103.03 million for the quarter, compared to analyst estimates of $102.69 million. sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.08 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 8th. Investors of record on Friday, November 17th will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Thursday, November 16th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.21%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 48.19%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Be the first to comment

Leave a Reply

Your email address will not be published.


*